Endometrial cancer is termed as the abnormal growth of endometrium cells in the uterus, also known as uterine cancer. Endometrial cancer is often diagnosed at an early stage due to the most common symptom being abnormal vaginal bleeding.
The global endometrial cancer market is estimated to witness remarkable growth due to the increasing prevalence of endometrial cancer. Other influential factors such as the growing obesity among women, rise in menopausal hormone therapy, change in an inactive lifestyle, socioeconomic factors, increasing consumption of an unhealthy diet, increasing prevalence of Polycystic Ovarian Syndrome (PCOS), and growing occurrence of breast or ovarian tumor are contributing towards the market growth. Additionally, diabetes is another risk factor that leads to endometrial cancer. However, factors such as high expenditure of diagnostic measures, expensive treatments, and side effects related to hysterectomy measures are estimated to hamper the market growth during the forecast period.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6226
Leading Key Players
The prominent players involved in the market are
- Pfizer Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Bayer AG
- Celgene Corporation
- Johnson & Johnson
- CooperSurgical Inc.
- LiNA Medical USA
- Conceptus Inc.
and Many More..
The global endometrial cancer market is segmented based on diagnosis, treatment, end-user, and region.
Based on the diagnosis, the endometrial cancer market is segmented into endometrial biopsy, ultrasound, dilation and curettage (D&C), pelvic examination, transvaginal and laparoscopy.
Based on treatment, the market has been segmented into radiation, chemotherapy, hysterectomy techniques, hormone therapy, and palliative care. The radiation category is segmented into external radiation and internal radiation (brachytherapy). The chemotherapy segment is segmented into paclitaxel, doxorubicin, carboplatin, and cisplatin. The hysterectomy techniques segment is sub-segmented into total vaginal hysterectomy, total laparoscopic hysterectomy, open abdominal hysterectomy, and robotic hysterectomy. Hormonal therapy is sub-segmented into luteinizing hormone-releasing hormone agonists, tamoxifen, progestins, and aromatase inhibitors.
Based on end-user, the global endometrial cancer market is segmented into hospitals and clinics, diagnostic centers, gynecology centers, ambulatory surgical centers, feminist health centers, and others.
Based on the region, the global endometrial cancer market is segmented into the North & Latin America, Europe, Asia-Pacific, and the Middle East and Africa.
The regional segmentation of the global endometrial cancer market has been segmented into The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas currently hold the largest market share, and during the forecast period, they are expected to retain their spot.
This region is experiencing a growing number of endometrial patients who are spending much on diagnostic and treatment. Due to a well-structured healthcare system and extensive research units, the market is strong in this region.
In the Americas, North America is a bigger market than South America because, in North America, more advanced medical facilities and population with higher per capita income are available. The biggest country based markets in this region are the United States of America (USA) and Canada.
Currently, Europe is the second largest market. Robust healthcare sector and advanced technologies are the driving factors for the European market. Due to reasons same as The Americas, Western Europe is a bigger market than Eastern Europe.
OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312